 |
 |
|
|
|
|
Title: |
EP0219076A2:
Sustained release composition[German][French]
[ Derwent Title ]

|
Country:
Kind: |
EP European Patent Office (EPO)
A2 APPLICATION PUBLISHED WITHOUT SEARCH REPORT i
(See also:
EP0219076A3,
EP0219076B1 )

|
| |
Inventor: |
Fujioka, Keiji;
Sato, Shigeji;
Tamura, Nobuhiko;
Takada, Yoshihiro;

|
Assignee: |
SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
News, Profiles, Stocks and More about this company

|
Published / Filed: |
1987-04-22
/ 1986-10-10

|
Application Number: |
EP1986000114067

|
IPC Code: |
Advanced:
A61K 9/20;
A61K 9/22;
IPC-7:
A61K 9/22;
A61K 37/02;
A61K 37/36;

|
ECLA Code: |
A61K9/20H6D2;

|
Priority Number: |

|
Abstract: |
A sustained release composition applicable for human beings and mammals which comprises (a) a silicone elastomer and (b) a pharmaceutical substance optionally with (c) albumin. When the pharmaceutical substance is of high molecular weight and can exert its pharmaceutical effect in a trace amount, its continuous release over a long period is attained by application of this invention.

|
INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report

|
Designated Country: |
AT BE CH DE ES FR GB IT LI NL SE

|
Family: |
Show 15 known family members

|
First Claim:
Show all claims |
1. A sustained release composition which comprises a silicone elastomer and a high molecular weight pharmaceutical substance contained therein.

|
Description
Expand description |
The present invention relates to a sustained release composition. More particularly, it relates to a long-term sustained release composition to be applied to mammals or human beings which comprises a pharmaceutical (i.e. pharmacologically or physiologically active) substance, particularly of high molecular weight, as an active ingredient and can maintain an effective level of said pharmaceutical substance over a long period of time.
+ Example 1
+ Example 2
+ Example 3
+ Example 4
+ Test 1
+ Test 2
+ Example 5
+ Example 6
+ Example 7
+ Example 8
+ Test 3
+ Test 4
+ Test 5
+ Test 6

|